Welcome to the Levitz Lab in the Division of Infectious Diseases and Immunology

Our lab is a part of both the Division of Infectious Diseases and Immunology in the Department of Medicine and the Program In Innate Immunity (PII), an interdisciplinary and interdepartmental group of investigators focused on discovering the underlying mechanisms that drive immune defenses and inflammation.

Our Research Focus: The immunology of fungal infections

Vaccine development in Cryptococcus neoformans
Eosinophil cytokine production in allergic aspergillosis
Identification of immunoreactive fungal proteins

Representative Publications

Specht CA, Homan EJ, Lee CK, Mou Z, Gomez CL, Hester MM, Abraham A, Rus F, Ostroff GR, Levitz SM. 2022. Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles. mBio 13:e03367-21.
Yadav B, Specht CA, Lee CK, Pokrovskii M, Huh JR, Littman DR, Levitz SM. Lung eosinophils elicited during allergic and acute aspergillosis express RORγt and IL-23R but do not require IL-23 for IL-17 production. PLoS Pathog. 2021 Aug 31;17(8):e1009891.
Hester MM, Lee CK, Abraham A, Khoshkenar P, Ostroff GR, Levitz SM, Specht CA. Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens. Vaccine. 2020 Jan 16;38(3):620-626.

More Publications

Page Menu